Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record for RRADICAL is now displayed, with study design, participant criteria, treatment details, outcome measures, and record dates. The page also includes study documents and notes that no Statistical Analysis Plan exists.SummaryDifference50%

- Check8 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 while the study page displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA site-wide NIH announcement about website changes appears above the ClinicalTrials.gov 403 error page. The site revision also advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page components related to study documents and metadata (including the SAP note and several document entries) have been removed, reducing the amount of visible procedural and documentation information on the study record.SummaryDifference18%

- Check57 days agoChange DetectedThe revision history now shows version 3.7.0 in place of 3.6.6, reflecting a new page update.SummaryDifference0.1%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.